BIO-RAD LABORATORIES, INC. - CL A (BIO)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A
Shares, excl. options Q1 2024
17.9 M
Holdings value Q1 2024
$6.2 B
Value change Q1 2024
-$149 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
447
Number of buys Q1 2024
211
Number of sells Q1 2024
-221
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.003%
CUSIP
090572207
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 11 K $3.01 M +$152 K $273.11 7
2024 Q1 17.9 M $6.2 B -$149 M $345.87 447
2023 Q4 18.2 M $5.87 B -$30.7 M $322.89 465
2023 Q3 18.5 M $6.61 B -$44.5 M $358.45 456
2023 Q2 18 M $6.81 B -$285 M $379.12 453
2023 Q1 19.2 M $9.17 B +$15.2 M $479.02 491
2022 Q4 19.2 M $8.08 B -$118 M $420.49 463
2022 Q3 19.4 M $8.11 B +$124 M $417.14 466
2022 Q2 19.1 M $9.43 B +$41.8 M $495.00 482
2022 Q1 19 M $10.7 B -$22.2 M $563.23 494
2021 Q4 19 M $14.3 B -$395 M $755.57 512
2021 Q3 18.9 M $14.1 B -$164 M $745.95 489
2021 Q2 17.7 M $11.4 B -$227 M $644.29 493
2021 Q1 19.5 M $11.1 B -$15 M $571.17 475
2020 Q4 19.6 M $11.4 B +$305 M $582.94 477
2020 Q3 18.9 M $9.72 B +$12.1 M $515.46 470
2020 Q2 19.2 M $8.66 B +$204 M $451.49 461
2020 Q1 18.7 M $6.57 B -$13.6 M $350.56 392
2019 Q4 18.9 M $6.98 B -$71.2 M $370.03 375
2019 Q3 19.1 M $6.35 B +$145 M $332.74 347
2019 Q2 18.7 M $5.84 B -$162 M $312.59 327
2019 Q1 19.3 M $5.91 B +$30.1 M $305.68 338
2018 Q4 19 M $4.41 B -$56.4 M $232.22 320
2018 Q3 18.9 M $5.91 B +$12.2 M $312.99 334
2018 Q2 19.1 M $5.5 B -$44.1 M $288.54 316
2018 Q1 19.3 M $4.82 B +$31.8 M $250.08 310
2017 Q4 19.2 M $4.58 B +$6.46 M $238.67 298
2017 Q3 19.2 M $4.26 B +$85 M $222.22 271
2017 Q2 18.8 M $4.26 B -$40.1 M $226.31 274
2017 Q1 19 M $3.8 B +$209 M $199.34 269
2016 Q4 19.7 M $3.59 B +$100 M $182.28 254
2016 Q3 19.1 M $3.12 B -$2.04 M $163.81 235
2016 Q2 18.8 M $2.69 B +$70.2 M $143.02 228
2016 Q1 18.3 M $2.5 B -$31 M $136.72 223
2015 Q4 18.5 M $2.57 B -$16.3 M $138.66 234
2015 Q3 18.8 M $2.53 B +$40.7 M $134.31 240
2015 Q2 18.7 M $2.81 B -$21.2 M $150.61 221
2015 Q1 18.9 M $2.55 B +$11.1 M $135.18 213
2014 Q4 18.8 M $2.27 B +$15.4 M $120.56 210
2014 Q3 18.4 M $2.09 B +$35.4 M $113.40 198
2014 Q2 18.3 M $2.19 B +$17.3 M $119.71 201
2014 Q1 18.1 M $2.31 B -$21.7 M $128.12 188